[Pharmacological and pharmacokinetic features and clinical effects of pitavastatin (Livalo Tablet)].

Author: FujinoHideki, KanazawaMizuho, KitaharaMasaki, SatoFumiyasu, SuzukiMikio, TamakiTaro, YamazakiHiroyuki

Paper Details 
Original Abstract of the Article :
Today 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (statins) are the most often prescribed drugs among the therapeutics for hypercholesterolemia. Pitavastatin is a novel statin that has been developed entirely in Japan from the biological screening to clinical studies persuin...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1254/fpj.123.349

データ提供:米国国立医学図書館(NLM)

Pitavastatin: A Novel Statin for Hypercholesterolemia

This research delves into the world of statins, a class of medications widely used to lower cholesterol levels. It introduces pitavastatin, a novel statin that has shown promising results in preclinical and clinical studies. The researchers highlight pitavastatin's unique properties, including its selective distribution to the liver, prolonged plasma half-life, and minimal drug interactions.

Pitavastatin: A Potential Game-Changer for Cholesterol Management

Pitavastatin demonstrated significant efficacy in lowering cholesterol levels in clinical trials, showing a reduction of 28% in total cholesterol and 40% in LDL cholesterol. This suggests that pitavastatin could be a valuable addition to the arsenal of medications available for managing hypercholesterolemia.

Promoting Cardiovascular Health

This research underscores the importance of managing cholesterol levels for cardiovascular health. Pitavastatin's potential as a safe and effective cholesterol-lowering medication offers hope for improving cardiovascular outcomes.

Dr. Camel's Conclusion

This study provides valuable insights into the potential of pitavastatin as a promising new statin for the management of hypercholesterolemia. The researchers' findings highlight the ongoing efforts to develop innovative treatments for cardiovascular disease and improve the health and well-being of individuals at risk.

Date :
  1. Date Completed 2004-07-30
  2. Date Revised 2019-09-01
Further Info :

Pubmed ID

15118259

DOI: Digital Object Identifier

10.1254/fpj.123.349

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.